Extended Data Table 3 Patient biomarker values

From: Lymph-node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: the phase 1 AMPLIFY-201 trial

  1. Longitudinal biomarker values for patients collected during screening, treatment and follow-up. ctDNA was reported in MTM/ml; CA 19-9 was reported in U ml−1; and CEA was reported in ng ml−1.
Back to article page